Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer

J D Graham1, D L Bain, J K Richer

  • 1Department of Medicine, University of Colorado School of Medicine, Denver, CO 80262, USA. dinny.graham@uchsc.edu

Steroids
|December 8, 2000
PubMed

Insights

Tamoxifen resistance in breast cancer may be linked to changes in nuclear receptor coregulators. Understanding these factors could reveal new therapeutic targets for overcoming resistance to endocrine therapy.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Tamoxifen resistance is a major challenge in breast cancer treatment, even with continued estrogen receptor (ER) expression.
  • Tamoxifen acts as a mixed antagonist, possessing both agonist and antagonist properties.
  • Resistance may arise from tamoxifen exhibiting more agonist-like properties, potentially stimulating tumor growth.

Purpose of the Study:

  • To investigate the role of nuclear receptor coregulators in tamoxifen resistance.
  • To identify proteins influencing tamoxifen's agonist and antagonist activities.
  • To explore the correlation between coregulator levels and tamoxifen sensitivity in breast tumors.

Main Methods:

  • Utilized a mixed antagonist-biased two-hybrid screening to identify coregulators.
  • Conducted transcriptional studies to assess the impact of N-CoR and L7/SPA on tamoxifen and RU486 activity.
  • Employed quantitative RT-PCR to measure transcript levels of coregulators (N-CoR, SMRT, L7/SPA, SRC-1) in tumor samples.

Main Results:

  • Identified N-CoR (nuclear receptor corepressor) and L7/SPA (coactivator) as key proteins influencing nuclear receptor activity.
  • N-CoR suppressed agonist properties of tamoxifen and RU486, while L7/SPA enhanced them.
  • Preliminary data suggest that relative levels of these coregulators may influence tamoxifen's agonist/antagonist balance.

Conclusions:

  • The balance of agonist and antagonist properties of mixed antagonists like tamoxifen may be determined by coregulator expression levels.
  • Tumor sensitivity to tamoxifen might be regulated by a complex interplay of transcription factors.
  • Further research is needed to fully understand these transcription factors and their role in endocrine therapy resistance.

Related Concept Videos

Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...